Skip to main content

Animations

MJFF Publications

2411 - 2420 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2025
  • 2020
  • 2018
  • 2025
  • 2023
  • 2023
  • 2020
  • 2024
  • 2021
  • Summary Details
    OPEN
    Title: Unique Astrocyte Cytoskeletal and Nuclear Morphology in a Three-Dimensional Tissue-Engineered Rostral Migratory Stream
    Journal Name: Neuroglia
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/neuroglia3010003
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf202
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.27219
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-023-07118-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Bi-allelic truncating variants in CASP2 underlie a neurodevelopmental disorder with lissencephaly
    Journal Name: European Journal of Human Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41431-023-01461-2
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2020.108386
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Associations of dual-task walking costs with cognition in Parkinson’s disease
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2024.03.002
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001
    Citation Count: 15
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.